横紋筋肉腫(Rhabdomyosarcoma)：治療薬開発パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Rhabdomyosarcoma Overview 6
Therapeutics Development 7
Pipeline Products for Rhabdomyosarcoma – Overview 7
Pipeline Products for Rhabdomyosarcoma – Comparative Analysis 8
Rhabdomyosarcoma – Therapeutics under Development by Companies 9
Rhabdomyosarcoma – Therapeutics under Investigation by Universities/Institutes 10
Rhabdomyosarcoma – Pipeline Products Glance 11
Clinical Stage Products 11
Rhabdomyosarcoma – Products under Development by Companies 12
Rhabdomyosarcoma – Products under Investigation by Universities/Institutes 13
Rhabdomyosarcoma – Companies Involved in Therapeutics Development 14
Bellicum Pharmaceuticals, Inc. 14
Boehringer Ingelheim GmbH 15
Celgene Corporation 16
Eisai Co., Ltd. 17
GlaxoSmithKline plc 18
Merrimack Pharmaceuticals, Inc. 19
Neotropix, Inc. 20
Novartis AG 21
Rhabdomyosarcoma – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Target 23
Assessment by Mechanism of Action 25
Assessment by Route of Administration 27
Assessment by Molecule Type 29
Drug Profiles 31
afatinib – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Cell Therapy for GD2 Expressing Solid Tumors – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
celyvir – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Dendritic Cell Therapy to Target MAGE-A1, MAGE-A3 and NY-ESO-1 for Oncology – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
E-7438 – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
everolimus – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
irinotecan sucrosofate liposomal – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
NTX-010 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
paclitaxel albumin bound – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
pazopanib hydrochloride – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Rhabdomyosarcoma – Recent Pipeline Updates 58
Rhabdomyosarcoma – Dormant Projects 84
Rhabdomyosarcoma – Discontinued Products 85
Appendix 86
Methodology 86
Coverage 86
Secondary Research 86
Primary Research 86
Expert Panel Validation 86
Contact Us 86
Disclaimer 87